13F Pro Quality Score

65.6/100

Rank #569 of 2,879 stocksTOP 25%

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

69.1/100

Profitability

67.3/100

Balance Sheet

68.3/100

Earnings Quality

75.2/100

Free Cash Flow

51.9/100

Institutional Flow

3.2/100

Revenue Scale

85.3/100

Dilution Risk

71.1/100

XYL Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Xylem Inc. (XYL), a Industrials sector company. 13F Pro's AI-powered ranking engine scores XYL at 65.6/100 on a 32-signal composite quality model, placing it at rank #569 of 2,879 stocks — the top 25% of the AI-ranked universe. XYL scores in the top quartile across revenue scale (85.3), earnings quality (75.2). Areas of concern include institutional flow (3.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Xylem Inc. reports quarterly revenue of $2.1B, net income of $193.0M, an operating margin of 11.5%. Top institutional holders of XYL by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. XYL trades on the NYSE exchange and files with the SEC under CIK 1524472. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate XYL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Xylem Inc. directly from SEC EDGAR. Xylem Inc.'s 13F Pro composite quality score has ranged between 8 and 74 since 2021, currently 65.6 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Revenue

Q1 2026

$2.1B

Net Income

Q1 2026

$193.0M

Free Cash Flow

Q1 2026

$18.0M

Operating Margin

Q1 2026

11.5%

D/E Ratio

Q1 2026

0.18

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+5.5% YoY
$9.04BFY 2025
FY19 $5.25BFY22 $5.52BFY24 $8.56BFY25 $9.04B

Net Income

+7.5% YoY
$957.0MFY 2025
FY19 $401.0MFY22 $355.0MFY24 $890.0MFY25 $957.0M

Operating Income

+21.2% YoY
$1.22BFY 2025
FY19 $486.0MFY22 $622.0MFY24 $1.01BFY25 $1.22B

EPS (Diluted)

+7.4% YoY
$3.92FY 2025
FY19 $2.21FY22 $1.96FY24 $3.65FY25 $3.92

Total Assets

+6.9% YoY
$17.63BFY 2025
FY19 $7.71BFY22 $7.95BFY24 $16.49BFY25 $17.63B

Total Debt

-3.7% YoY
$1.94BFY 2025
FY19 $2.32BFY22 $1.88BFY24 $2.02BFY25 $1.94B

Op. Cash Flow

-1.7% YoY
$1.24BFY 2025
FY19 $839.0MFY22 $596.0MFY24 $1.26BFY25 $1.24B

AI Insight: XYL Financial Trends

Xylem's operating margin hit a multi-quarter high in Q4 2025 at 14.7%, while debt has declined four consecutive quarters to $1,938M — balance sheet steadily strengthening.

Revenue grew year-over-year in every comparable quarter: Q2 2025 $2,301M vs Q2 2024 $2,169M; Q4 2025 $2,397M vs Q4 2024 $2,256M.

Operating income expanded from $253M in Q2 2024 to $334M in Q3 2025 and $353M in Q4 2025, reflecting consistent margin improvement.

Total debt declined from $2,016M in Q4 2024 to $1,938M in Q1 2026, the lowest level in the observed period.

Q1 operating cash flow remains seasonally weak: $33M in Q1 2025 and $108M in Q1 2026, versus $543M in Q4 2025.

Q1 2026 operating CF of $108M is the second-lowest in the dataset — confirm whether Q1 seasonal weakness is deepening or stable.

Equity dipped from $11,480M in Q4 2025 to $10,972M in Q1 2026 — first sequential decline in six quarters; worth monitoring.

Q1 2026 net income of $193M vs Q1 2025 $169M shows year-over-year improvement — sustaining this trajectory is key.

AI Insight: XYL Ratio Trends

Xylem's ROIC has trended higher year-over-year but Q1 2026 seasonality dragged all returns metrics to their second-lowest readings in the dataset.

Operating margin improved from 11.7% in Q2 2024 to 14.7% in both Q3 and Q4 2025, signaling underlying margin expansion.

ROIC rose from 8.2% in Q2 2024 to a peak of 10.5% in Q4 2025, before retreating to 7.6% in Q1 2026.

D/E ratio edged down from 0.19 across Q2 2024–Q1 2025 to 0.17 in Q4 2025, indicating modest deleveraging.

Q1 2026 operating margin of 11.5% nearly matches the weakest quarter in the dataset (Q1 2025 at 11.2%), consistent with seasonal patterns.

Q1 2026 ROIC of 7.6% is the lowest outside Q1 2025 — confirm Q2 2026 rebounds toward Q3–Q4 2025 levels of 10%+.

ROE dropped sharply to 7.0% in Q1 2026 from 11.7% in Q4 2025; watch whether full-year TTM ROE stabilizes or drifts lower.

D/E ticked back up to 0.18 in Q1 2026 after reaching 0.17 in Q4 2025 — monitor whether deleveraging trend resumes.

Get alerted when XYL's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Xylem Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of XYL

Put XYL on your watchlist

Track score changes the day Xylem Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is XYL a good stock to buy?

13F Pro's AI-powered analysis of Xylem Inc. (XYL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for XYL are available on the XYL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own XYL?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling XYL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Xylem Inc.'s investment landscape.